ALLO
Price:
$2.41
Market Cap:
$503.96M
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic CAR T cell product candidate that is in Phase I clinical trial for the treatment of R/R non-Hodgkin lymphoma; and ALLO-501A, which is in Phase I/II clinical trial for the treatment R/R large B-cell lymphoma or transformed follicular lymphoma. In addi...[Read more]
Industry
Biotechnology
IPO Date
2018-10-11
Stock Exchange
NASDAQ
Ticker
ALLO
According to Allogene Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Allogene Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ALLO's Dividend Yield was at its highest in in the December 2017 quarter at 0%. The Dividend Yield was at its lowest in in the December 2017 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Allogene Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
The current Dividend Yield of Allogene Therapeutics, Inc. (ALLO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Allogene Therapeutics, Inc.’s Dividend Yield is less than G1 Therapeutics, Inc. (0%), less than Heron Therapeutics, Inc. (0%), less than Annexon, Inc. (0%), less than Sangamo Therapeutics, Inc. (0%), less than Beam Therapeutics Inc. (0%), less than Sana Biotechnology, Inc. (0%), less than Caribou Biosciences, Inc. (0%), less than Editas Medicine, Inc. (0%), less than Theseus Pharmaceuticals, Inc. (0%), less than aTyr Pharma, Inc. (0%), less than Relay Therapeutics, Inc. (0%), less than Century Therapeutics, Inc. (0%), less than Blueprint Medicines Corporation (0%), less than Intellia Therapeutics, Inc. (0%), less than Verve Therapeutics, Inc. (0%), less than Prime Medicine, Inc. (0%), less than iTeos Therapeutics, Inc. (0%), less than Icosavax, Inc. (0%), less than Mirati Therapeutics, Inc. (0%), less than VectivBio Holding AG (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $376.17M | |
0% | $273.00M | |
0% | $607.51M | |
0% | $150.54M | |
0% | $1.92B | |
0% | $1.12B | |
0% | $155.42M | |
0% | $296.09M | |
0% | $181.50M | |
0% | $131.12M | |
0% | $835.47M | |
0% | $123.69M | |
0% | $5.47B | |
0% | $2.00B | |
0% | $473.47M | |
0% | $426.11M | |
0% | $540.52M | |
0% | $769.04M | |
0% | $4.12B | |
0% | $1.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allogene Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Allogene Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Allogene Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Allogene Therapeutics, Inc. (ALLO)?
What is the highest Dividend Yield for Allogene Therapeutics, Inc. (ALLO)?
What is the 3-year average Dividend Yield for Allogene Therapeutics, Inc. (ALLO)?
What is the 5-year average Dividend Yield for Allogene Therapeutics, Inc. (ALLO)?
How does the current Dividend Yield for Allogene Therapeutics, Inc. (ALLO) compare to its historical average?